[Flunarizine in epilepsy. Evaluation of a 4-month supplementary treatment in patients resistant to treatment with existing antiepileptics].
Twenty patients affected with a form of epilepsy resistant to treatment received 10 to 20 mg of flunarizine per day in addition to the anti-epileptic medication. The majority of the patients suffered from partial epilepsy with or without secondary generalization. The flunarizine treatment was evaluated after four months. On the whole, flunarizine was well tolerated. The number of attacks was reduced by 50% or more in half the patients.
Sorel
L
L
Centre Neurologique William Lennox, Ottignies.
D000328:Adult; D000927:Anticonvulsants / Q000008:administration & dosage*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004827:Epilepsy / Q000188:drug therapy*; D005260:Female; D005444:Flunarizine / Q000008:administration & dosage* / Q000009:adverse effects; D006801:Humans; D008297:Male; D008875:Middle Aged
D000927:Anticonvulsants; D005444:Flunarizine
La flunarizine dans l'épilepsie. Evaluation d'un traitement "additif" de quatre mois chez des patients résistants au traitement antiépileptique existant.